ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,103Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 944

$441K Total Retail Price of All Prescriptions

Rank: 277 out of 944

594 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 594 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 12,348 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
SIMVASTATIN 1,184 1,137 1 1
LISINOPRIL 700 642 2 3
LEVOTHYROXINE SODIUM 516 493 3 2
METOPROLOL SUCCINATE 512 503 4 14
METOPROLOL TARTRATE 493 455 5 8
AMLODIPINE BESYLATE 476 459 6 5
ATENOLOL 475 466 7 11
WARFARIN SODIUM 407 397 8 7
METFORMIN HCL 339 315 9 12
OMEPRAZOLE 334 316 10 4
HYDROCHLOROTHIAZIDE 330 311 11 9
LOSARTAN POTASSIUM 312 308 12 16
FUROSEMIDE 303 295 13 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 215 186 14 29
SERTRALINE HCL 201 197 15 23
POTASSIUM CHLORIDE 175 173 16 15
PRAVASTATIN SODIUM 163 161 17 17
ALENDRONATE SODIUM 152 149 18 20
LOVASTATIN 151 147 19 26
TRIAMTERENE-HCTZ 132 132 20 33
ISOSORBIDE MONONITRATE ER 125 123 21 52
ADVAIR DISKUS 117 112 22 31
TAMSULOSIN HCL 111 111 23 27
HYDROCODONE-ACETAMINOPHEN 103 82 S3 24 10
CLOPIDOGREL 103 95 24 36
DIGOXIN 100 88 26 39
ALLOPURINOL 91 91 27 22
ZOLPIDEM TARTRATE 90 81 28 25
CARBIDOPA-LEVODOPA 87 84 29 77
OXYBUTYNIN CHLORIDE 80 80 30 94
LOSARTAN-HYDROCHLOROTHIAZIDE 78 63 31 54
GABAPENTIN 77 59 32 18
FLUOXETINE HCL 77 77 32 48
PANTOPRAZOLE SODIUM 75 72 34 34
PLAVIX 73 73 35 55
DIOVAN 73 58 35 38
AMITRIPTYLINE HCL 73 72 R 35 79
PREDNISONE 72 71 38 32
GLIPIZIDE ER 71 70 39 89
LABETALOL HCL 69 69 40 154
DOXAZOSIN MESYLATE 68 66 41 60
ADACEL 65 61 42 284
TRAZODONE HCL 64 64 43 45
CITALOPRAM HBR 62 62 44 19
ATORVASTATIN CALCIUM 61 54 45 13
SPIRONOLACTONE 60 45 46 44
FINASTERIDE 59 59 47 83
TRAMADOL HCL 58 47 48 21
ENALAPRIL MALEATE 58 58 48 43
LANTUS 56 49 50 46
PAROXETINE HCL 56 56 50 64
VERAPAMIL ER 56 56 50 120
FLUTICASONE PROPIONATE 55 49 53 40
NABUMETONE 54 31 54 174
VENTOLIN HFA 54 53 54 116
DILTIAZEM ER 53 53 56 88
RANITIDINE HCL 53 50 56 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.